L1TD1 Activateurs
L1TD1 (LINE-1 type transposase domain-containing 1), also known as ECAT11 (embryonic stem cell-associated transcript 11), is a protein that in humans is encoded by the L1TD1 gene. This protein is known for its high expression in pluripotent stem cells, including embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), and is considered a marker of pluripotency.The L1TD1 protein is believed to have originated from a transposable element, specifically a LINE-1 retrotransposon, which is a type of "jumping gene" that can move around within the genome. Although most transposable elements are inactive in humans, some of their remnants have been co-opted during evolution for beneficial uses in the host genome. L1TD1 is one such example, having evolved a function that supports the stem cell state.
The precise role of L1TD1 in stem cells is not fully understood, but it is thought to contribute to the maintenance of their pluripotent state, possibly through interactions with key pluripotency factors or influencing gene expression patterns. It has been suggested that L1TD1 may be involved in RNA processing or the regulation of gene expression, given its association with ribonucleoprotein particles and involvement in the formation of stress granules.Mutations or dysregulation of L1TD1 expression may have implications for stem cell function and could potentially impact cellular differentiation and development. Due to its specific expression in pluripotent stem cells, L1TD1 is also of interest in the field of regenerative medicine, as it could serve as a biomarker for the quality and pluripotency of stem cell preparations.
VOIR ÉGALEMENT...
| Nom du produit | CAS # | Ref. Catalogue | Quantité | Prix HT | CITATIONS | Classement |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
L'acide rétinoïque peut influencer la différenciation des cellules souches, en affectant potentiellement l'expression de L1TD1, qui est impliqué dans la régulation de la pluripotence. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
La forskoline, en augmentant l'AMPc, peut influencer diverses voies de signalisation dans les cellules souches, ce qui pourrait avoir un impact sur l'expression de L1TD1. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
La 5-Azacytidine, un inhibiteur de l'ADN méthyltransférase, peut affecter l'expression des gènes dans les cellules souches, ce qui pourrait avoir un impact sur L1TD1. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $153.00 $520.00 | 4 | |
CHIR99021, un inhibiteur de GSK-3, favorise la pluripotence et pourrait avoir un impact sur l'expression de L1TD1 dans les cellules souches. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
Le SB431542 est un inhibiteur du récepteur TGF-beta, qui peut influencer la pluripotence des cellules souches et potentiellement l'expression de L1TD1. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
L'acide valproïque, un inhibiteur d'histone-désacétylase, peut affecter le remodelage de la chromatine et l'expression des gènes dans les cellules souches, ce qui pourrait avoir un impact sur L1TD1. | ||||||